drugset
drugset / Trial / NCT02637193

A Study to Assess The Effects Of Effexor XR On Cardiac Repolarization In Healthy Adult Subjects

NCT02637193 ↗

Phase 1 Completed 54 enrolled Viatris Inc.
RandomizedCrossoverQuadruple-blindOther

Summary

The purpose of this study is to demonstrate a lack of effect of venlafaxine (Effexor XR) on QTc intervals relative to time matched placebo in healthy volunteers

Timeline

Start
2015-12
Primary completion
2016-07
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Moxifloxacin Small molecule 400 mg —
Subject Venlafaxine Small molecule 225 mg —

Indications

No indication recorded.